Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< RESEARCH IN PSYCHIATRY

January 2024

PSYCHIATRY

NEURAL MECHANISMS MAY SERVE AS THERAPEUTIC TARGET FOR DEPRESSION

Featuring: Vijay Mittal, PhD, Stewart Shankman, PhD

​A recent study published in Molecular Psychiatry has identified previously unknown alterations in neural connectivity that promote psychomotor disturbance — a slowing or reduction in movement — in individuals with major depressive disorder.

“There seems to be a clear underlying pattern of brain connectivity that is tied to these motor features as well as to subtypes of depression. This could lead to new treatments (targeting motor function), as well as more accurate ways of defining and treating people with depression,” said Vijay Mittal, PhD, professor of Medical Social Sciences, of Psychiatry and Behavioral Sciences, and the David S. Homes Professor of Brain Science and chair of Psychology at the Weinberg College of Arts and Sciences, who was a co-author of the study.

​Stewart Shankman, PhD, the Dunbar Professor of Bipolar Disease and a professor of Psychiatry and Behavioral Sciences, was a co-author of the study.

Approximately 280 million people worldwide live with major depressive disorder (MDD), according to the World Health Organization, and may experience a range of symptoms including disrupted sleep, poor concentration, feelings of low self-worth, as well as psychomotor disturbance.

Up to 70 percent of individuals with MDD experience psychomotor disturbance, presenting as either psychomotor retardation — a reduction in movement and activity — or psychomotor agitation — repetitive movements resulting in restlessness.

Psychomotor disturbance has previously been associated with a higher severity of MDD and poorer response to antidepressant treatments. However, the underlying neural mechanisms have remained poorly understood.

In the current study, a total of 699 participants with remitted or current depression and 820 healthy controls were categorized into displaying psychomotor retardation, psychomotor agitation or no psychomotor disturbance.

​MRIs of each participant were then compared to determine functional connectivity between different sections of the brain’s cerebral motor network, which included the primary motor cortex, supplementary motor area, sensory cortex, superior parietal lobe, caudate, putamen, pallidum, thalamus and cerebellum.

Overall, participants with psychomotor retardation only had higher thalamo-cortical connectivity, while those with psychomotor agitation had higher pallido-cortical connectivity. Participants with current MDD but without psychomotor disturbance also showed higher thalamo-cortical, pallido-cortical, and cortico-cortical connectivity, as well as higher alterations in overall network connectivity compared to controls.

Remitted patients with psychomotor disturbance showed no differences in single connections but differences in overall network connectivity, while remitted patients without psychomotor disturbance demonstrated connectivity signatures similar to the control group.

Moving forward, Mittal said his team hopes to repeat the study with multimodal neuroimaging and clinical assess participants’ motor symptoms to determine the root causes of psychomotor retardation and psychomotor agitation.

This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG; Forschungsgruppe/Research Unit FOR2107).
This article was originally published in the Northwestern University Feinberg School of Medicine  on January 11,  2024.
Vijay Mittal, PhD headshot
Vijay Mittal, PhD, professor of Medical Social Sciences, of Psychiatry and Behavioral Sciences, and the David S. Homes Professor of Brain Science and chair of Psychology at the Weinberg College of Arts and Sciences, was a co-author of the study published in Molecular Psychiatry.
Stewart Shankman, PhD headshot
Stewart Shankman, PhD, the Dunbar Professor of Bipolar Disease and a professor of Psychiatry and Behavioral Sciences, was a co-author of the study.

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you in caring for your patients. ​
Call 844.344.6663
Find an NM Psychiatrist

You May Also Like

​Sachin Patel, MD, PhD headshot

January 2023

PSYCHIATRY
Medical School Establishes New Center for Psychiatric Neuroscience
Kaitlyn N. Kunstman, MD  headshot

December 2022

PSYCHIATRY
Northwestern Medicine Gender Pathways Program
Sheehan Fisher, PhD headshot

October 2022

PSYCHIATRY
Gender Inequities That Affect Maternal and Paternal Mental Health

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties